|
🐜
|
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
22 auth.
R. Hogg,
V. Lima,
J. Sterne,
S. Grabar,
M. Battegay,
M. Bonarek,
A. Monforte,
A. Esteve,
M. Gill,
Ross J. Harris,
...
A. Justice,
A. Hayden,
F. Lampe,
A. Mocroft,
J. Wasmuth,
M. Mugavero,
S. Staszewski,
A. Sighem,
M. Kitahata,
J. Guest,
M. Egger,
M. May
|
10 |
2008 |
10
🐜
|
|
🐜
|
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
27 auth.
A. Rauch,
Z. Kutalik,
P. Descombes,
T. Cai,
J. di Iulio,
T. Mueller,
M. Bochud,
M. Battegay,
E. Bernasconi,
J. Borovička,
S. Colombo,
A. Cerny,
J. Dufour,
H. Furrer,
H. Günthard,
...
M. Heim,
B. Hirschel,
R. Malinverni,
D. Moradpour,
B. Müllhaupt,
A. Witteck,
J. Beckmann,
T. Berg,
S. Bergmann,
F. Negro,
A. Telenti,
P. Bochud
|
10 |
2010 |
10
🐜
|
|
🐬
|
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Gilbert GREUB,
B. Ledergerber,
M. Battegay,
P. Grob,
for the Swiss Hiv Cohort Study
|
9 |
2000 |
9
🐬
|
|
🐜
|
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
189 auth.
Alison Rodger,
V. Cambiano,
T. Bruun,
P. Vernazza,
S. Collins,
Olaf Degen,
G. Corbelli,
Vicente Estrada,
A. Geretti,
A. Beloukas,
D. Raben,
P. Coll,
Andrea Antinori,
N. Nwokolo,
Armin Rieger,
...
Jan M Prins,
Anders Blaxhult,
Rainer Weber,
A. van Eeden,
Norbert H Brockmeyer,
Amanda Clarke,
J. del Romero Guerrero,
François Raffi,
Johannes R. Bogner,
Gilles Wandeler,
J. Gerstoft,
F. Gutiérrez,
K. Brinkman,
M. Kitchen,
Lars Ostergaard,
Agathe Leon,
Matti Ristola,
Heiko Jessen,
H. Stellbrink,
A. Phillips,
J. Lundgren,
P. Coll,
Patricia Cobarsí,
A. Nieto,
M. Meulbroek,
A. Carrillo,
J. Saz,
J. D. Guerrero,
Margarida García,
F. Gutiérrez,
M. Masiá,
Catalina Robledano,
Agathe Leon,
L. Leal,
E. Redondo,
Vicente Estrada,
Rocio Marquez,
R. Sandoval,
P. Viciana,
N. Espinosa,
L. López-Cortés,
D. Podzamczer,
J. Tiraboschi,
Sandra Morenilla,
A. Antela,
E. Losada,
N. Nwokolo,
J. Sewell,
Amanda Clarke,
Sarah Kirk,
Alyson Knott,
Alison Rodger,
T. Fernandez,
M. Gompels,
L. Jennings,
Lana Ward,
J. Fox,
J. Lwanga,
M. Lee,
R. Gilson,
C. Leen,
S. Morris,
D. Clutterbuck,
M. Brady,
D. Asboe,
S. Fedele,
S. Fidler,
Norbert H Brockmeyer,
A. Potthoff,
A. Skaletz‐Rorowski,
Johannes R. Bogner,
U. Seybold,
J. Roider,
Heiko Jessen,
A. Jessen,
S. Ruzicic,
H. Stellbrink,
T. Kümmerle,
C. Lehmann,
Olaf Degen,
Sindy Bartel,
A. Hüfner,
J. Rockstroh,
Karina Mohrmann,
C. Boesecke,
I. Krznaric,
P. Ingiliz,
Rainer Weber,
Christina Grube,
D. Braun,
H. Günthard,
Gilles Wandeler,
H. Furrer,
A. Rauch,
P. Vernazza,
P. Schmid,
M. Rasi,
D. Boršo,
M. Stratmann,
Oliver Caviezel,
M. Stoeckle,
M. Battegay,
P. Tarr,
V. Christinet,
Florent Jouinot,
Camille Isambert,
E. Bernasconi,
B. Bernasconi,
J. Gerstoft,
L. P. Jensen,
A. Bayer,
Lars Ostergaard,
Y. Yehdego,
Ann L E Bach,
Pia Handberg,
G. Kronborg,
S. Pedersen,
Nete Bülow,
Bente Ramskover,
Matti Ristola,
Outi Debnam,
Jussi Sutinen,
Anders Blaxhult,
R. Ask,
Bernt Hildingsson-Lundh,
K. Westling,
Eeva-Maija Frisen,
G. Cortney,
S. O’Dea,
S. De Wit,
C. Necsoi,
L. Vandekerckhove,
J. Goffard,
S. Henrard,
Jan M Prins,
H. Nobel,
A. Weijsenfeld,
A. van Eeden,
L. Elsenburg,
K. Brinkman,
D. Vos,
Imke Hoijenga,
E. Gisolf,
P. van Bentum,
D. Verhagen,
François Raffi,
E. Billaud,
M. Ohayon,
D. Gosset,
Alexandre Fior,
G. Pialoux,
P. Thibaut,
J. Chas,
V. Leclercq,
V. Péchenot,
V. Coquelin,
C. Pradier,
S. Breaud,
Veronique Touzeau-Romer,
Armin Rieger,
Maria Kitchen - Maria Geit,
M. Sarcletti,
M. Gisinger,
Angela Oellinger,
Andrea Antinori,
S. Menichetti,
T. Bini,
C. Mussini,
Marianna Meschiari,
A. di Biagio,
L. Taramasso,
B. Celesia,
M. Gussio,
N. Janeiro
|
9 |
2019 |
9
🐜
|
|
🐢
|
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
10 auth.
M. Egger,
B. Hirschel,
P. Francioli,
P. Sudre,
Marc Wirz,
M. Flepp,
...
M. Rickenbach,
R. Malinverni,
P. Vernazza,
M. Battegay
|
9 |
1997 |
9
🐢
|
|
🐜
|
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.
9 auth.
B. Hasse,
B. Ledergerber,
H. Furrer,
M. Battegay,
B. Hirschel,
M. Cavassini,
...
B. Bertisch,
E. Bernasconi,
R. Weber
|
9 |
2011 |
9
🐜
|
|
🦁
|
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.
M. Battegay,
S. Cooper,
A. Althage,
J. Bänziger,
H. Hengartner,
R. Zinkernagel
|
8 |
1991 |
8
🦁
|
|
🐜
|
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.
13 auth.
M. Salathé,
C. Althaus,
R. Neher,
S. Stringhini,
E. Hodcroft,
J. Fellay,
M. Zwahlen,
G. Senti,
M. Battegay,
A. Wilder-Smith,
...
I. Eckerle,
M. Egger,
N. Low
|
8 |
2020 |
8
🐜
|
|
🐢
|
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
13 auth.
G. Kaufmann,
L. Perrin,
G. Pantaleo,
M. Opravil,
H. Furrer,
A. Telenti,
B. Hirschel,
B. Ledergerber,
P. Vernazza,
E. Bernasconi,
...
M. Rickenbach,
M. Egger,
M. Battegay
|
8 |
2003 |
8
🐢
|
|
🦁
|
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice
M. Battegay,
D. Moskophidis,
A. Rahemtulla,
H. Hengartner,
T. Mak,
R. Zinkernagel
|
8 |
1994 |
8
🦁
|
|
🐜
|
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
13 auth.
R. Weber,
M. Ruppik,
M. Rickenbach,
A. Spoerri,
H. Furrer,
M. Battegay,
M. Cavassini,
A. Calmy,
E. Bernasconi,
P. Schmid,
...
M. Flepp,
J. Kowalska,
B. Ledergerber
|
8 |
2013 |
8
🐜
|
|
🐜
|
Fibroblasts as efficient antigen-presenting cells in lymphoid organs.
10 auth.
T. Kündig,
M. Bachmann,
C. DiPaolo,
J. Simard,
M. Battegay,
H. Lother,
...
A. Gessner,
K. Kuhlcke,
P. Ohashi,
H. Hengartner
|
8 |
1995 |
8
🐜
|
|
🐢
|
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
11 auth.
G. Kaufmann,
H. Furrer,
B. Ledergerber,
L. Perrin,
M. Opravil,
P. Vernazza,
...
M. Cavassini,
E. Bernasconi,
M. Rickenbach,
B. Hirschel,
M. Battegay
|
8 |
2005 |
8
🐢
|
